Welcome to our store

News

GHK-Cu vs. GLP-1: Bone Loss Risk in Menopause a...

June 23, 2026

GLP-1 agonists reduce bone density in menopausal women, while GHK-Cu and kisspeptin offer complementary skeletal protection through collagen synthesis and osteoclast inhibition.

GHK-Cu vs. GLP-1: Bone Loss Risk in Menopause a...

June 23, 2026

GLP-1 agonists reduce bone density in menopausal women, while GHK-Cu and kisspeptin offer complementary skeletal protection through collagen synthesis and osteoclast inhibition.

Welland Peptides (PC)

High-quality peptides designed for consistency, purity, and trusted research performance.

QUICK LINKS

OUR POLICIES

CONTACT

info@wellandpeptides.ca

2327 Victoria Ave, Regina, SK, S4P 0S7

⚠ Research Use Only — Legal Disclaimer

Research Use Only — By purchasing any product from this website, you confirm that you are a qualified researcher or licensed professional acquiring these compounds solely for legitimate scientific research in a controlled laboratory environment. These products are not intended for human or animal consumption, are not approved by Health Canada, the FDA, or any other regulatory body, and must not be used for therapeutic, diagnostic, or personal purposes. You accept full and sole responsibility for lawful, compliant, and safe handling of all purchased compounds. We expressly disclaim any and all liability for adverse effects, injury, misuse, or regulatory violation of any kind.